Skip to main content
. 2021 Nov 7;10(11):2720. doi: 10.3390/foods10112720

Table 3.

Effects of B. rapa 143N5 and 163N7 cultivars and gluconapin (GNA) treatments on the D. melanogaster average lifespan and healthspan (75%).

Compound Concentration (mg/mL) Lifespan
Average
(days)
Mean Lifespan Difference
(%)
Healthspan Average
(days)
Mean Healthspan Difference
(%)
B. rapa 143N5 control 46.365 16.929
0.31 49.506 7 19.231 13
0.625 56.332 ** 21 30.308 79
1.25 62.747 *** 35 31.714 * 87
2.5 55.891 ** 20 16.000 −5
5 54.611 * 18 23.286 37
B. rapa 163N7 control 46.365 16.929
0.31 58.098 ** 25 40.238 137
0.625 58.510 * 26 42.679 * 152
1.25 57.908 ** 26 40.302 * 138
2.5 57.917 *** 25 34.574 104
5 72.066 *** 55 59.854 * 253
GNA control 46.365 16.929
0.0069 59.931 *** 29 26.357 55
0.0137 55.157 *** 19 18.143 7
0.0275 51.819 ** 12 18.700 10
0.055 48.241 4 17.929 6
0.11 49.828 * 7 17.500 3

Means were calculated by the Kaplan–Meier method, and significance of the curves was determined by the Log-Rank method (Mantel–Cox). *: significant (p < 0.05), **: highly significant (p < 0.01), ***: very highly significant (p < 0.001).